Developer docs
API playgroundTry for free, no card

Search company profiles

Evamed

Full company profile

uuid000ex5i

Namestring
Evamed
Legal namestring
1MED SA
Websiteurl
evamed.fr
Company typeenum
Private
Founded yearint
2005
Descriptiontext

Evamed is a France-based clinical research company founded in 2005 and headquartered in Hérouville-Saint-Clair, Normandy. The firm specializes in the evaluation and clinical investigation of medical devices, serving medical device developers that require clinical evidence generation and regulatory-grade clinical investigation support within European frameworks.

The company operates as a privately held, for-profit organization with a workforce in the 11-50 employee band. Its functional scope centers on clinical evaluation and clinical investigation of medical devices, indicating a service offering built around clinical trial execution, clinical evaluation reports, and supporting evidence generation for medical device regulatory submissions. Beyond the firmographic core, the company description provided in the input is thin: no products, proprietary platforms, named customers, revenue, or pricing disclosures are explicitly attached to Evamed. The company website (evamed.fr) is the primary public reference point identified.

Evamed's business model and go-to-market specifics are not disclosed in the supplied data. As a small European specialty CRO with no listed investors beyond an early-stage incubation engagement from Normandie Incubation in December 2005, the operating model is consistent with a boutique clinical research services firm rather than a scaled enterprise CRO. Customer segment data, contract structure, and revenue mechanics are not provided, which limits the ability to characterize the commercial model in detail.

Short descriptiontext

Evamed is a France-based clinical research company founded in 2005 that specializes in the evaluation and clinical investigation of medical devices for medical device developers. It operates as a privately held boutique CRO with 11-50 employees based in Hérouville-Saint-Clair.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHérouville-saint-clair, France
HQ citystring
Hérouville-saint-clair
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, medical device evaluation, regulatory consultancy, clinical trial management, post-market surveillance
Industry3 codes
PRIMARYHLACAOAI
Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAN
Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Custom Computer Programming Services541511
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Prepackaged Software7372
Product category
Medical Device Clinical Research Services (MedTech CRO)
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CRO Services
TypeProfessional Services
Description

Full-service clinical research organization services including clinical trial management, pre and post market trial support, regulatory consultancy, and quality management. Services span product development from implementation of Quality Management Systems (ISO 13485) to regulatory documentation and clinical studies across all phases in Europe and beyond.

1med.net
2Digital Solutions (1Survey+)
TypeSubscription Recurring
Description

Clinical-grade digital platform subscription for PMCF, PMS, Real-World Evidence, and technical documentation. Platform provides data collection that transforms directly into regulatory documentation.

1med.net
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
11Survey+
Description

The first clinical-grade platform for PMCF (Post-Market Clinical Follow-up) and Real-World Evidence. Engineered to meet MDR standards, it generates Level-4 evidence aligning clinical methodology, ISO 14155 expectations, and real-time data integrity into a validated process. Features include AI agents for quality monitoring and real-time blockchain validation.

1med.net
Core offering1 text field

Evamed is a specialty MedTech clinical research organization that delivers clinical and regulatory support, quality management, clinical trial management, pre- and post-market trial services, biometrics, and medical writing for medical device and combination product developers across Europe and beyond. Its flagship digital offering, 1Survey+, is the first clinical-grade platform purpose-built for Post-Market Clinical Follow-Up (PMCF) and Real-World Evidence generation, embedding EU MDR standards, ISO 14155-aligned methodology, blockchain-based data validation, and integrated AI quality monitoring into a single validated process.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Level-4 clinical evidence generation
Product overview1 text field

1MED operates as a specialty MedTech and combination product CRO offering clinical and regulatory support, quality management, clinical trial management, pre and post market trial support, biometrics, medical writing, and digital solutions. The company's primary digital product is 1Survey+, a clinical-grade platform for PMCF and Real-World Evidence generation. Additional service offerings include Regulatory Services, Quality Services, CRO Services for the MedTech industry, CRO Services for Combination Products, and Post-Market Services.

Product and service1 record
11Survey+
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

TÜV, a leading Notified Body, collaborates with 1MED on educational webinars focused on MDR compliance, data quality, and PMCF strategies. The partnership includes joint events such as webinars featuring TÜV experts discussing audit pitfalls, ISO 14155 requirements, and defensible PMCF data strategies.

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Peers10 records
1NAMSA
TypeDirect peer
Description

NAMSA is the world's leading specialty MedTech CRO offering regulatory, quality, clinical, and laboratory services across the device lifecycle. It is the closest direct peer to 1MED given its MedTech-only focus and full continuum of MDR/IVDR-aligned services.

TypeBroad incumbent
Description

Medpace is a large global CRO with a dedicated medical device and diagnostics unit offering clinical trial management, regulatory support, and biometrics. It competes with 1MED on MedTech trials but serves many more therapeutic verticals at much larger scale.

TypeBroad incumbent
Description

ICON is one of the largest global CROs with a dedicated medical device and combination product practice through its Medical Device & Diagnostics Research group. They overlap with 1MED on regulatory-clinical services for MedTech sponsors but offer a much broader service portfolio.

TypeBroad incumbent
Description

Charles River operates a global CRO business that includes medical device and IVD clinical and regulatory services via its CDMO/CRO network. Comparable to 1MED in clinical and regulatory depth for MedTech, but operates at much larger scale and broader life-science scope.

TypeDirect peer
Description

RQM+ is a MedTech-focused regulatory, quality, and clinical consultancy serving device OEMs under MDR/IVDR. Highly comparable to 1MED in niche specialty CRO positioning, regulatory depth, and combination-product expertise.

TypeBroad incumbent
Description

IQVIA is the world's largest CRO with a MedTech and devices practice spanning regulatory affairs, clinical operations, and real-world evidence. It competes with 1MED primarily on the largest MedTech engagements requiring global reach and integrated technology.

TypeBroad incumbent
Description

Eurofins provides testing, certification, and clinical research services to MedTech and IVD developers including MDR/IVDR testing and clinical studies. It overlaps with 1MED on IVD and MedTech clinical evidence work but is fundamentally a broader testing-and-laboratory conglomerate.

8TÜV SÜD
TypeOthers
Description

TÜV SÜD is a Notified Body and certification provider that partners with 1MED on PMCF and MDR-compliance webinars. While not a CRO, TÜV SÜD's adjacent regulatory and medical device testing services frame 1MED's competitive set and partner ecosystem.

TypeBroad incumbent
Description

WuXi AppTec provides global CRO and CDMO services with a clinical research arm supporting medical device and combination product sponsors. Comparable as a broad-scope life sciences services platform, though WuXi's depth on MedTech-specific PMCF is more limited than 1MED's specialty focus.

TypeEmerging player
Description

Catalent provides clinical and combination-product development services for drug-device developers. While pharma-biased, its combination-product and biologics-clinical capabilities overlap with 1MED's combination-product CRO offering for MedTech OEMs.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Evamed

Medical Device Clinical Research Services (MedTech CRO)evamed.fr

Evamed is a France-based clinical research company founded in 2005 that specializes in the evaluation and clinical investigation of medical devices for medical device developers. It operates as a privately held boutique CRO with 11-50 employees based in Hérouville-Saint-Clair.

What Evamed does

Evamed is a France-based clinical research company founded in 2005 and headquartered in Hérouville-Saint-Clair, Normandy. The firm specializes in the evaluation and clinical investigation of medical devices, serving medical device developers that require clinical evidence generation and regulatory-grade clinical investigation support within European frameworks.

The company operates as a privately held, for-profit organization with a workforce in the 11-50 employee band. Its functional scope centers on clinical evaluation and clinical investigation of medical devices, indicating a service offering built around clinical trial execution, clinical evaluation reports, and supporting evidence generation for medical device regulatory submissions. Beyond the firmographic core, the company description provided in the input is thin: no products, proprietary platforms, named customers, revenue, or pricing disclosures are explicitly attached to Evamed. The company website (evamed.fr) is the primary public reference point identified.

Evamed's business model and go-to-market specifics are not disclosed in the supplied data. As a small European specialty CRO with no listed investors beyond an early-stage incubation engagement from Normandie Incubation in December 2005, the operating model is consistent with a boutique clinical research services firm rather than a scaled enterprise CRO. Customer segment data, contract structure, and revenue mechanics are not provided, which limits the ability to characterize the commercial model in detail.

Evamed firmographics

Firmographics
Name
Evamed
Legal name
1MED SA
Website
https://evamed.fr
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
11–50 employees
Short description
Evamed is a France-based clinical research company founded in 2005 that specializes in the evaluation and clinical investigation of medical devices for medical device developers. It operates as a privately held boutique CRO with 11-50 employees based in Hérouville-Saint-Clair.
Ownership category
akta.pro rank

Evamed industry classification

Industry
Product category
Medical Device Clinical Research Services (MedTech CRO)
NAICS
Medical and Diagnostic Laboratories (62151), Custom Computer Programming Services (541511)
SIC
Services-Medical Laboratories (8071), Services-Prepackaged Software (7372)
akta.pro industry
PRIMARYHLACAOAI
Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)
SECONDARYHLAGAJAI
Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACAOAN
Regulatory Submissions & Clinical Content Management (eCTD/Publishing)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Trials & Research Informatics (eCOA/ePRO/EDC)

Keywords

  • Clinical research services
  • Medical device evaluation
  • Regulatory consultancy
  • Clinical trial management
  • Post-market surveillance

Where Evamed is headquartered

Location

Headquarters

HQ city
Hérouville-saint-clair
HQ country
France
HQ region
Europe

Offices1 record

Markets served

Evamed business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. CRO Services: Full-service clinical research organization services including clinical trial management, pre and post market trial support, regulatory consultancy, and quality management. Services span product development from implementation of Quality Management Systems (ISO 13485) to regulatory documentation and clinical studies across all phases in Europe and beyond.
  2. Digital Solutions (1Survey+): Clinical-grade digital platform subscription for PMCF, PMS, Real-World Evidence, and technical documentation. Platform provides data collection that transforms directly into regulatory documentation.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Evamed product offering

Product offering

Core offering

Evamed is a specialty MedTech clinical research organization that delivers clinical and regulatory support, quality management, clinical trial management, pre- and post-market trial services, biometrics, and medical writing for medical device and combination product developers across Europe and beyond. Its flagship digital offering, 1Survey+, is the first clinical-grade platform purpose-built for Post-Market Clinical Follow-Up (PMCF) and Real-World Evidence generation, embedding EU MDR standards, ISO 14155-aligned methodology, blockchain-based data validation, and integrated AI quality monitoring into a single validated process.

Product overview

1MED operates as a specialty MedTech and combination product CRO offering clinical and regulatory support, quality management, clinical trial management, pre and post market trial support, biometrics, medical writing, and digital solutions. The company's primary digital product is 1Survey+, a clinical-grade platform for PMCF and Real-World Evidence generation. Additional service offerings include Regulatory Services, Quality Services, CRO Services for the MedTech industry, CRO Services for Combination Products, and Post-Market Services.

Differentiator

Problem solved

Functional benefit

Brands

  • 1Survey+: The first clinical-grade platform for PMCF (Post-Market Clinical Follow-up) and Real-World Evidence. Engineered to meet MDR standards, it generates Level-4 evidence aligning clinical methodology, ISO 14155 expectations, and real-time data integrity into a validated process. Features include AI agents for quality monitoring and real-time blockchain validation.

Products and services

  • 1Survey+

Quantifiable outcome

  • Level-4 clinical evidence generation

Companies that use Evamed

Customer profile

Segments3 records

Ideal customer profiles3 records

Evamed technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Evamed partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • TÜVcoreStrategic or Co-development PartnerTÜV, a leading Notified Body, collaborates with 1MED on educational webinars focused on MDR compliance, data quality, and PMCF strategies. The partnership includes joint events such as webinars featuring TÜV experts discussing audit pitfalls, ISO 14155 requirements, and defensible PMCF data strategies.

Scale indicators2 records

Recent moves1 record

Evamed competitors and assessment

Company assessment

Direct peers

  • NAMSA: NAMSA is the world's leading specialty MedTech CRO offering regulatory, quality, clinical, and laboratory services across the device lifecycle. It is the closest direct peer to 1MED given its MedTech-only focus and full continuum of MDR/IVDR-aligned services.
  • RQM+ (formerly RCRI): RQM+ is a MedTech-focused regulatory, quality, and clinical consultancy serving device OEMs under MDR/IVDR. Highly comparable to 1MED in niche specialty CRO positioning, regulatory depth, and combination-product expertise.

Broad incumbents

  • Medpace: Medpace is a large global CRO with a dedicated medical device and diagnostics unit offering clinical trial management, regulatory support, and biometrics. It competes with 1MED on MedTech trials but serves many more therapeutic verticals at much larger scale.
  • ICON plc: ICON is one of the largest global CROs with a dedicated medical device and combination product practice through its Medical Device & Diagnostics Research group. They overlap with 1MED on regulatory-clinical services for MedTech sponsors but offer a much broader service portfolio.
  • Charles River Laboratories: Charles River operates a global CRO business that includes medical device and IVD clinical and regulatory services via its CDMO/CRO network. Comparable to 1MED in clinical and regulatory depth for MedTech, but operates at much larger scale and broader life-science scope.
  • IQVIA: IQVIA is the world's largest CRO with a MedTech and devices practice spanning regulatory affairs, clinical operations, and real-world evidence. It competes with 1MED primarily on the largest MedTech engagements requiring global reach and integrated technology.
  • Eurofins Scientific: Eurofins provides testing, certification, and clinical research services to MedTech and IVD developers including MDR/IVDR testing and clinical studies. It overlaps with 1MED on IVD and MedTech clinical evidence work but is fundamentally a broader testing-and-laboratory conglomerate.
  • WuXi AppTec: WuXi AppTec provides global CRO and CDMO services with a clinical research arm supporting medical device and combination product sponsors. Comparable as a broad-scope life sciences services platform, though WuXi's depth on MedTech-specific PMCF is more limited than 1MED's specialty focus.

Others

  • TÜV SÜD: TÜV SÜD is a Notified Body and certification provider that partners with 1MED on PMCF and MDR-compliance webinars. While not a CRO, TÜV SÜD's adjacent regulatory and medical device testing services frame 1MED's competitive set and partner ecosystem.

Emerging players

  • Catalent (now Novo Holdings-owned): Catalent provides clinical and combination-product development services for drug-device developers. While pharma-biased, its combination-product and biologics-clinical capabilities overlap with 1MED's combination-product CRO offering for MedTech OEMs.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat2 records

Key risks7 records

Key highlights7 records

Customer concentration

Evamed social profiles

Digital presence

Evamed compliance and trust

Trust signal

Compliance1 record

Evamed financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Evamed leadership team

Management profile

Number of profiles

Profiles1 record

Evamed funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Evamed M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evamed

What does Evamed do?

Evamed is a specialty MedTech clinical research organization that delivers clinical and regulatory support, quality management, clinical trial management, pre- and post-market trial services, biometrics, and medical writing for medical device and combination product developers across Europe and beyond. Its flagship digital offering, 1Survey+, is the first clinical-grade platform purpose-built for Post-Market Clinical Follow-Up (PMCF) and Real-World Evidence generation, embedding EU MDR standards, ISO 14155-aligned methodology, blockchain-based data validation, and integrated AI quality monitoring into a single validated process.

Is Evamed a public or private company?

Evamed is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Evamed founded?

Evamed was founded in 2005. It employs 11 to 50 people.

Where is Evamed based?

Evamed is headquartered in Hérouville-saint-clair, France, in the Europe region.

How does Evamed make money?

Two revenue lines are on record. CRO Services are the primary driver. The others are digital Solutions (1Survey+).

Who are Evamed's main competitors?

Direct peers on record are NAMSA and RQM+ (formerly RCRI). Broad incumbents are Medpace, ICON plc, Charles River Laboratories, IQVIA, Eurofins Scientific and WuXi AppTec. TÜV SÜD is listed as an others. Catalent (now Novo Holdings-owned) is listed as an emerging player.

Does Evamed have an API?

No public API is recorded for Evamed.

What industry is Evamed in?

Evamed's product category is Medical Device Clinical Research Services (MedTech CRO). Its primary akta.pro industry code is HLACAOAI, Clinical Trial Analytics, Risk-Based Monitoring (RBM) & Quality Management, with a secondary code of HLAGAJAI, Quality, Compliance & Validation Software for Labs (GxP/CSV, eQMS for QC Labs). Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales